Although the precise mechanisms governing the tumor-induced immune tolerance are still elusive, a constitutive activation of Stat3 in most tumors plays a crucial role in the formation of tumor-induced immune tolerance [6]. The gene discussed is STAT3; the disease is neoplasm.